EASL Studio: Midday Talks on Improving Liver Cancer Care and Prevention - 23 June 2022

EASL Studio: Midday Talks: HBV and HDV drug development - Where do we stand and where are we going? - 23 June 2022

EASL Studio: London Calling - 23 June 2022

EASL Studio Podcast: Midday Talks on Improving Liver Cancer Care and Prevention - 23 June 2022

EASL Studio Podcast: Midday Talks: HBV and HDV drug development - Where do we stand and where are we going? - 23 June 2022

EASL Studio Podcast: Teatime - 23 June 2022

EASL Studio: Teatime - 22 June 2022

EASL Studio: Midday Talks: NAFLD Roundtable - Towards effective interventions in NAFLD - 22 June 2022

EASL Studio: London Calling - 22 June 2022

EASL Studio Podcast: Midday Talks: NAFLD Roundtable - Towards effective interventions in NAFLD - 22 June 2022

EASL Studio Podcast: Teatime - 22 June 2022

EASL Studio S2 E17: EASL Haemochromatosis Guidelines 2022

EASL Studio Podcast S2 E17: EASL Haemochromatosis Guidelines 2022

EASL Studio S2 E16: The NAFLD pandemic

EASL Studio Podcast S2 E16: The NAFLD pandemic

EASL Studio S2 E15: JHEP Live on the best animal model for HCC – Lost in translation?

EASL Studio Podcast S2 E15: JHEP Live on the best animal model for HCC – Lost in translation?

EASL Studio S2 E14: Elastography – The new non-invasive gold standard in portal hypertension?

EASL Studio Podcast S2 E14: Elastography – The new non-invasive gold standard in portal hypertension?

EASL Studio Special Edition: Unexplained acute hepatitis in children